SNDX - Syndax announces proposed $150M public offering of common stock
2023-12-14 16:04:01 ET
More on Syndax Pharmaceuticals
- Syndax Pharmaceuticals Inc (SNDX) Q3 2023 Earnings Call Transcript
- Syndax: Biotech To Watch With Regulatory Filings Before End Of 2023
- Syndax reports encouraging Phase 1 data for leukemia drug
- BofA starts Syndax at buy, cites "first mover advantage" for leukemia drug
- Seeking Alpha’s Quant Rating on Syndax Pharmaceuticals
For further details see:
Syndax announces proposed $150M public offering of common stock